Roche acquires RNAi technology firm Mirus Bio for $125mm

02 Nov 2011

Roche has acquired private Mirus Bio (nucleic acid delivery and research products) for $125mm.

Pharmaceuticals
Research, Analytical Equipment & Supplies
Pharmaceuticals
- Vaccines
- Drug Delivery
  - Macromolecule
Biotechnology
- Antisense, Oligonucleotides
- Gene Therapy, Cell Therapy
- Large Molecule

Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Payment Includes Cash

Already a Biomedtracker subscriber? You have access to the full deal record through your subscription

Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Related Companies

Roche acquires RNAi technology firm Mirus Bio for $125mm

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice